Does Dr. GEOFFREY GURTNER have financial conflicts of interest?

Dr. GEOFFREY GURTNER (M.D.) has received a total of $92,934 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $92,934 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GEOFFREY GURTNER?

According to CMS Open Payments data, Dr. GEOFFREY GURTNER received funding from MOLNLYCKE HEALTH CARE US ($39,628), DAVOL ($20,632), and NOVO NORDISK AS ($14,680).

Does Dr. GEOFFREY GURTNER receive research grants or speaking fees?

Dr. GEOFFREY GURTNER has received $92,934 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GEOFFREY GURTNER

M.D.Real-Time Hydrated

Specialty: Surgery, Plastic and Reconstructive Surgery

Practice Location: PALO ALTO, CA 94304

NPI Number: 1891830881

LIFETIME INDUSTRY VALUE

$92,934

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GURTNER is a verified Surgery, Plastic and Reconstructive Surgery practitioner based in PALO ALTO, CA.

Between 2021 and 2025, Dr. GURTNER had an overall industry promotional and research financial footprint of $92,934 as recorded in the federal CMS Open Payments database.

$92,934 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GURTNER's primary funding source is MOLNLYCKE HEALTH CARE US, which accounts for $39,628 (representing 42.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MOLNLYCKE HEALTH CARE US

Rank 1

$39,628

42.6%

DAVOL

Rank 2

$20,632

22.2%

NOVO NORDISK AS

Rank 3

$14,680

15.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.